Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients after HLA-Matched Allogeneic Stem Cell Transplantation

American Journal of Transplantation

Volumn 15, Issue 8, 2015, Pages 2170-2179

  Ritter, J ^a   Seitz, V ^a,b   Balzer, H ^c   Gary, R ^c   Lenze, D ^a   Moi, S ^c   Pasemann, S ^c   Seegebarth, A ^a   Wurdack, M ^c   Hennig, S ^b   Gerbitz, A ^c   Hummel, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HS Diagnomics GmbH   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Bone marrow; cytomegalovirus (CMV); donors and donation; Epstein Barr virus (EBV); hematopoietic stem cell transplantation; infection and infectious agents; infectious disease; molecular biology; science; T cell biology; translational research

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; HLA ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APHERESIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DONOR; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HLA MATCHING; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; MALE; MIDDLE AGED; PRIORITY JOURNAL; STEM CELL MOBILIZATION; T LYMPHOCYTE SUBPOPULATION; VIRUS REACTIVATION; YOUNG ADULT; ALLOTRANSPLANTATION; CASE CONTROL STUDY; IMMUNOLOGY; STEM CELL TRANSPLANTATION; VALIDATION STUDY; VIRUS ACTIVATION;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 84937525888     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13241     Document Type: Article

References (28)

1. Theilgaard-Monch K, Raaschou-Jensen K, Andersen H, et al., Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Bone Marrow Transplant 1999; 3: 243-249.
2. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JL., Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 12: 4422-4429.
3. Seggewiss R, Einsele H., Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: An update. Blood 2010; 19: 3861-3868.
4. Fallen PR, McGreavey L, Madrigal JA, et al., Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 10: 1001-1014.
5. Maury S, Mary JY, Rabian C, et al., Prolonged immune deficiency following allogeneic stem cell transplantation: Risk factors and complications in adult patients. Br J Haematol 2001; 3: 630-641.
6. Nikolich-Zugich J, Slifka MK, Messaoudi I., The many important facets of T-cell repertoire diversity. Nat Rev Immunol 2004; 2: 123-132.
7. Feuchtinger T, Lucke J, Hamprecht K, et al., Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2005; 4: 503-509.
8. Khan N., The immunological burden of human cytomegalovirus infection. Arch Immunol Ther Exp (Warsz) 2007; 5: 299-308.
9. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P., A direct estimate of the human alphabeta T cell receptor diversity. Science 1999; 5441: 958-961.
10. Langerak AW, van Den Beemd R, Wolvers-Tettero IL, et al., Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood 2001; 1: 165-173.
11. van den Beemd R, Boor PP, van Lochem EG, et al., Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000; 4: 336-345.
12. Friedman TM, Goldgirsh K, Berger SA, et al., Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: A new paradigm for designer allogeneic blood and marrow transplantation. Blood 2008; 8: 3517-3525.
13. Memon SA, Sportes C, Flomerfelt FA, Gress RE, Hakim FT., Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood. J Immunol Methods 2012; 1/2: 84-92.
14. Robins HS, Campregher PV, Srivastava SK, et al., Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 2009; 19: 4099-4107.
15. Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA., Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 2009; 10: 1817-1824.
16. Warren RL, Freeman JD, Zeng T, et al., Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res 2011; 5: 790-797.
17. Shannon CE., The mathematical theory of communication. 1963. MD Comput 1997; 4: 306-317.
18. + T cell receptor repertoire. Sci Transl Med 2010; 47: 47ra64.
19. van Dongen JJ, Langerak AW, Bruggemann M, et al., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-C T98-3936. Leukemia 2003; 12: 2257-2317.
20. Messaoudi I, Lemaoult J, Guevara-Patino JA, Metzner BM, Nikolich-Zugich J., Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense. J Exp Med 2004; 10: 1347-1358.
21. Gottschalk S, Rooney CM, Heslop HE., Post-transplant lymphoproliferative disorders. Annu Rev Med 2005; 56: 29-44.
22. Klarenbeek PL, Tak PP, van Schaik BD, et al., Human T-cell memory consists mainly of unexpanded clones. Immunol Lett 2010; 1: 42-48.
23. van Heijst JW, Ceberio I, Lipuma LB, et al., Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med 2013; 3: 372-377.
24. Goronzy JJ, Lee WW, Weyand CM., Aging and T-cell diversity. Exp Gerontol 2007; 5: 400-406.
25. Britanova OV, Putintseva EV, Shugay M, et al., Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J Immunol 2014; 6: 2689-2698.
26. Peggs KS, Verfuerth S, Pizzey A, Chow SL, Thomson K, Mackinnon S., Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation. Clin Infect Dis 2009; 12: 1851-1860.
27. Schmidt-Hieber M, Labopin M, Beelen D, et al., CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: A report from the Acute Leukemia Working Party of EBMT. Blood 2013; 19: 3359-3364.
28. Broers AE, van Der Holt R, van Esser JW, et al., Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 7: 2240-2245.